Related Experiment Video
Updated: Jun 22, 2026

07:35
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
Controlling feature selection in random forests of decision trees using a genetic algorithm: classification of class
Loren Hansen1, Ernestine A Lee, Kevin Hestir
1Program in Bioinformatics, Boston University, Boston, MA 02215, USA. hansenlo@ncbi.nlm.nih.gov
Combinatorial Chemistry & High Throughput Screening
|June 13, 2009
Summary
GenForest, a novel procedure using genetic algorithms for feature selection in random forests, demonstrated strong performance in the CoEPrA competition for classifying type I MHC nonapeptides.
Area of Science:
- Bioinformatics
- Computational Biology
- Machine Learning
Background:
- Feature selection is critical in classification tasks with high-dimensional data.
- Random forests are powerful ensemble methods for classification.
- Genetic algorithms offer robust optimization capabilities.
Purpose of the Study:
- To introduce GenForest, a method integrating genetic algorithms with random forests for enhanced feature selection.
- To evaluate GenForest's performance in a competitive, real-world classification challenge.
Main Methods:
- Developed GenForest, a procedure controlling feature selection within random forests using a genetic algorithm.
- Applied GenForest to classification problems in the Comparative Evaluation of Prediction Algorithms 2006 (CoEPrA) competition.
- Utilized a dataset with 5787 features per peptide for classifying type I MHC nonapeptides.
Main Results:
- GenForest achieved competitive rankings in the CoEPrA competition: 10/23 (Problem 1), 5/16 (Problem 3), and 9/16 (Problem 4).
- The method effectively handled high-dimensional data, classifying type I MHC nonapeptides.
Conclusions:
- GenForest provides an effective approach for feature selection in complex classification problems.
- The method's performance in the CoEPrA competition validates its utility for biological data analysis.
Related Concept Videos
Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
